(Total Views: 268)
Posted On: 03/13/2019 3:36:53 PM
Post# of 86239
There are lots of things going on with Univec and the good Doctor Dalton these days. We have Merck knocking on Dalton’s door asking for a deal. We have Harvest coming to Dalton and once again asking for a deal. We have MariMed and their proprietary Vitiprint technology that most industry experts agree is a real game changer. We have the V.A. and through clinics a direct supply line to Veterans in need of cannabis treatment. For most investors, any one of these developments would mean mega bucks, but we still have more. Doctor Dalton has PPSI a company that I believe is much larger than most people realize. We also have HRI, a company we know has something like 200 million in revenue (by the way, I suspect PPSI is a whole lot larger than HRI). There are other deals in play said to be even bigger than even the whispers seem to indicate (a Whole Foods deal for instance and an automobile deal and even a biofuel deal).
Some suggest it would not be that hard for Dalton to “put out the financials” so they can flip this stock. The problem with putting out the financials before all is final is that our competitors and partners would then be exposed. The idea is to burn the flippers and the doubters so prevalent on these forums. I personally would like to see these doubters and flippers burned because they are not true investors and have not even tried to figure out what is going on.
Imagine what a merger between Univec, Sativeo, AGRiMED, and Hemp Commodity Industries might mean. Yet, that is only the beginning of things. These companies are the low hanging fruit so often talked about on this forum. So consider a company merging and reorganizing with perhaps more than a billion dollars in revenue smack dab in the middle of the cannabis industry. A new company capable of treating nearly every major ailment known to man.
Imagine what a company like that might be worth, and imagine where a company like that might trade. Would a company like this be trading in the sewer of the OTC? I think not. Would a company such as this attract interest from hedge funds? I can not imagine why it would not.
Kgem
Some suggest it would not be that hard for Dalton to “put out the financials” so they can flip this stock. The problem with putting out the financials before all is final is that our competitors and partners would then be exposed. The idea is to burn the flippers and the doubters so prevalent on these forums. I personally would like to see these doubters and flippers burned because they are not true investors and have not even tried to figure out what is going on.
Imagine what a merger between Univec, Sativeo, AGRiMED, and Hemp Commodity Industries might mean. Yet, that is only the beginning of things. These companies are the low hanging fruit so often talked about on this forum. So consider a company merging and reorganizing with perhaps more than a billion dollars in revenue smack dab in the middle of the cannabis industry. A new company capable of treating nearly every major ailment known to man.
Imagine what a company like that might be worth, and imagine where a company like that might trade. Would a company like this be trading in the sewer of the OTC? I think not. Would a company such as this attract interest from hedge funds? I can not imagine why it would not.
Kgem
(3)
(0)Scroll down for more posts ▼
